Dergiler / International Dental Research / 2018 / Cilt: 8 - Sayı: 1

Cleidocranialdysplasia. Amolecularandclinicalreview

Sayfa
35–38
Yayın Tarihi
2022-10-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In this review,we also highlight very broadly the phenotypic characteristics of previously reported patients with CCD.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Cleidocranial dysplasia (CCD) is a rare autosomal dominant disorder characterized by skeletal and dental abnormalities primarily, short stature, aplasia or hypoplasia of clavicles, open fontanelles and supernumerary teeth.
📊
Temel Bulgular & Veri:Heterozygous mutations of the runt-related transcription factor 2 (RUNX2) gene have been found in approximately 60-70% of cases,leaving a large number of cases with no defined genetic cause which ledus to delve into molecular mechanisms underlying CCD and thus to detect potential target genes to be explored in these patients.
💡
Sonuç & Katkı:In this review,we also highlight very broadly the phenotypic characteristics of previously reported patients with CCD.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Cleidocranial dysplasia (CCD) is a rare autosomal dominant disorder characterized by skeletal and dental abnormalities primarily, short stature, aplasia or hypoplasia of clavicles, open fontanelles and supernumerary teeth. Heterozygous mutations of the runt-related transcription factor 2 (RUNX2) gene have been found in approximately 60-70% of cases,leaving a large number of cases with no defined genetic cause which ledus to delve into molecular mechanisms underlying CCD and thus to detect potential target genes to be explored in these patients. In this review,we also highlight very broadly the phenotypic characteristics of previously reported patients with CCD.

🔖

Bu Makaleye Atıf Yap

AVENDANO, A., CAMMARATA-SCALİSİ, F., BUDİARDJO, S. B., FAUZİAH, E., GRANDE, N. M., FORTUNATO, L., PLOTİNO, G., YAVUZ, İ., CALLEA, M., RİZAL, M. F. (2022). Cleidocranialdysplasia. Amolecularandclinicalreview. International Dental Research, Cilt: 8 - Sayı: 1, 35–38. https://ajindex.com/articles/539550

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Roberts T, Stephen L, Beighton P. Cleidocranial dysplasia: A review of the dental, historical, and practical implications with an overview of the South African experience. Oral Surg Oral Med Oral Pathol Oral Radiol 2013
  2. 46–55. [Crossref] 2.Mundlos S. Cleidocranial dysplasia: clinical and molecular genetics. J Med Genet 1999
  3. 177–82. 3.Patil P, Barpande S, Bhavthankar J, Humbe J. Cleidocranial dysplasia: A clinico-radiographic spectrum with differential diagnosis. J Orthop Case Reports 2015
  4. 21–4. 4.Jensen B. Somatic development in cleidocranial dysplasia. Am J Med Genet 1990
  5. 69–74. [Crossref] 5.Komori T. Signaling networks in RUNX2-dependent bone development. J Cell Biochem 2011
  6. 750–5. [Crossref] 6.Komori T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res 2010
  7. 189–95. [Crossref] 7.Bharti K, Goswami M. Cleidocranial dysplasia: A report of two cases with brief review. Intractable Rare Dis Res 2016
  8. 5(2):117–20. [Crossref] 8.Åberg T, Wang X, Kim J, Yamashiro T, Bei M, Rice R, et al. Runx2 mediates FGF signaling from epithelium to mesenchyme during tooth morphogenesis. Dev Biol 2004
  9. 76–93. [Crossref] 9.Zhang Y, Yasui N, Ito K, Huang G, Fujii M, Hanai J, et al. A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci 2000
  10. 10549–54.[Crossref] 10.Valenti MT, Dalle Carbonare L, Mottes M. Osteogenic differentiation in healthy and pathological conditions. Int J Mol Sci 2016
  11. e41–9. [Crossref] 11.JarugaA, Hordyjewska E, Kandzierski G, Przemk T. Cleidocraneal dysplasia and RUNX2-clinical phenotype genotype correlation. Clin Genet 2016
  12. 393–402. [Crossref] 12.Liu H, Sun Q, Wan C, Li L, Zhang L, Chen Z. MicroRNA-338-3p regulates osteogenic differentiation of mouse bone marrow stromal stem cells by targeting Runx2 and Fgfr2. J Cell Physiol 2014
  13. 1494–502. [Crossref] 13.Du F, Wu H, Zhou Z, Liu Y. MicroRNA-375 inhibits osteogenic differentiation by targeting runt-related transcription factor 2. Exp Ther Med 2015
  14. 207–12. [Crossref] 14.Sera SR, Zur Nieden NI. microRNA regulation of skeletal development. Curr Osteoporos Rep 2017
  15. 15(4):353–66. [Crossref] 15. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L, Groner Y. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 1994
  16. 425–32.[Crossref] 16.Mundlos S, Olsen BR. Herit